Bhavanish Life Sciences
Committed to Quality
Rich experience in developing high-quality active pharmaceutical ingredients and intermediates.
Intermediates & KSMs
Manufacturer and supplier of Key Starting Materials and Bulk Drug Intermediates. Our large intermediate and API plants handle complex reactions and manufacture to customer requirements.
Reference Standards & Impurities
Custom synthesis of complex organic compounds used as reference standards, nitroso impurities and impurity standards by formulation and bulk drug industries around the world.
Speciality Chemicals
Manufacturer and supplier of Speciality Chemicals and Raw Materials, produced commercially according to customer requirements, along with analytical standards, reagents and lab chemicals.
CDSCO
CDSCO regulates pharmaceuticals and medical devices in India, ensuring safety, efficacy and quality for public health.
CGMP
CGMP ensures pharmaceuticals are produced consistently to quality standards across manufacturing, packaging and distribution.
FDA
FDA regulates food, drugs, medical devices and cosmetics in the U.S., protecting public health through safety and quality standards.
Innovating Pharmaceutical Solutions with a Commitment to Quality
Bhavanish Life Sciences is a leading pharmaceutical company with extensive experience in developing high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. We excel in tackling the challenges of advanced API and intermediate development, ensuring commercial manufacturing that meets the highest standards in healthcare. Our commitment to quality extends to the production of pharmaceutical reference standards, impurities, analytical standards, and chemicals, all tailored for pharmaceutical use.
Our state-of-the-art facilities and dedicated research and development team enable us to innovate and maintain excellence in every product we manufacture. Our mission is to advance healthcare by supplying top-quality pharmaceutical products and services that meet the needs of the industry and improve patient outcomes.
Major Business
Empowering global health with innovative pharmaceutical solutions, driven by advanced research, quality excellence, and a commitment to improving lives through cutting-edge technologies and sustainable healthcare advancements.
- Pharmaceutical Reference Standards / Impurities / Analytical Standards / Reagents / Lab Chemicals
- Key Starting Materials / Bulk Drug Intermediates, manufactured commercially
- Speciality Chemicals and Raw Materials, manufactured commercially
Our Featured CDMO Offerings
(4S,5S)-Dimethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
View Details →
2-(Trifluoromethyl)phenylacetic acid
View Details →
4-(4,6-Dichloro-5-(2-methoxyphenoxy)pyrimidin-2-yl)picolinonitrile
View Details →
5-(2-Methoxyphenyl)cyclohexane-1,3-dione
View Details →
L-Homoserine Methyl Ester Hydrochloride
View Details →Get in Touch
Reach out to us for any inquiries or support through our phone, email, or by visiting our location. We are dedicated to providing assistance and ensuring your needs are met efficiently.
News & Articles
Aryl Hydrocarbon Receptor in Adipocyte Function and Lipid Metabolism: Dual Roles in Obesity
The aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor traditionally studied for its role in xenobiotic metabolism, has...
Read More
Selective Mitophagy and Protein Aggregate Accumulation in CMT4B3 Fibroblasts
Charcot-Marie-Tooth disease type 4B3 (CMT4B3) is a rare inherited neuropathy linked to mutations in the MTMR5/SBF1 gene. This...
Read More
Yokogawa and Repligen Collaborate to Advance Real-Time Bioprocess Monitoring
Yokogawa Corporation of America and Repligen have entered into a strategic partnership to integrate Yokogawa’s OpreX Bio Pilot...
Read More